Clinical Trials Directory

Trials / Completed

CompletedNCT05489367

Does COVİD-19 m-RNA Vaccine Affect Fertility and Over Reserve ?

Status
Completed
Phase
Study type
Observational
Enrollment
64 (actual)
Sponsor
Gaziosmanpasa Research and Education Hospital · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Women's ovarian reserve and fertility were compared before and after 2 doses of vaccination

Detailed description

our study ıs desıgned as an observatıonal clınıcal study. the purpose ıs to compare the over reserve tests of the patıents before and after vaccıne, to determıne ıf the over reserve and fertılıty of women are affected by the vaccıne.women who applied to the vaccination outpatient clinic for the first dose of vaccine were included in the study.those who have never been vaccinated and have not had covid 19 infection were included in the study.antı ullerıan hormone level ıs the laboratory parameters that best showıng the ovary reserve today. ovarian reserve tests including amh were checked and their fertility was questioned and their information was recorded. the same tests were repeated after the volunteers received 2 doses of vaccine. ın the power analysis, it was calculated that 104 volunteers should be included in the study.the study will be terminated when 104 volunteers are reached.

Conditions

Interventions

TypeNameDescription
BIOLOGICALsars cov 2 biontec vaccinevolunteers will be expected to receive 2 doses of vaccine

Timeline

Start date
2022-02-01
Primary completion
2022-10-20
Completion
2022-11-30
First posted
2022-08-05
Last updated
2023-02-22

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

Source: ClinicalTrials.gov record NCT05489367. Inclusion in this directory is not an endorsement.